Comparison of self-refraction using a simple device, USee, with manifest refraction in adults

PLoS One. 2018 Feb 1;13(2):e0192055. doi: 10.1371/journal.pone.0192055. eCollection 2018.

Abstract

Background: The USee device is a new self-refraction tool that allows users to determine their own refractive error. We evaluated the ease of use of USee in adults, and compared the refractive error correction achieved with USee to clinical manifest refraction.

Methods: Sixty adults with uncorrected visual acuity <20/30 and spherical equivalent between -6.00 and +6.00 diopters completed manifest refraction and self-refraction.

Results: Subjects had a mean (±SD) age of 53.1 (±18.6) years, and 27 (45.0%) were male. Mean (±SD) spherical equivalent measured by manifest refraction and self-refraction were -0.90 D (±2.53) and -1.22 diopters (±2.42), respectively (p = 0.001). The proportion of subjects correctable to ≥20/30 in the better eye was higher for manifest refraction (96.7%) than self-refraction (83.3%, p = 0.005). Failure to achieve visual acuity ≥20/30 with self-refraction in right eyes was associated with increasing age (per year, OR: 1.05; 95% CI: 1.00-1.10) and higher cylindrical power (per diopter, OR: 7.26; 95% CI: 1.88-28.1). Subjectively, 95% of participants thought USee was easy to use, 85% thought self-refraction correction was better than being uncorrected, 57% thought vision with self-refraction correction was similar to their current corrective lenses, and 53% rated their vision as "very good" or "excellent" with self-refraction.

Conclusion: Self-refraction provides acceptable refractive error correction in the majority of adults. Programs targeting resource-poor settings could potentially use USee to provide easy on-site refractive error correction.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Refractive Errors / diagnosis*
  • Refractive Errors / physiopathology
  • Visual Acuity
  • Young Adult

Grants and funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Global Vision 2020 holds the patent for the USee refraction tool that was evaluated by the study described in this article. J. Kevin White is the founder of Global Vision 2020 and also serves as its Executive Director. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.